F 0689
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Ensure that a nursing home area is free from accident hazards and provides adequate supervision to
prevent accidents.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observations, review of clinical records, select facility policies, and staff and resident interviews, it was
determined the facility failed to ensure the resident environment was free from potential accident hazards
related to unsecured medications on two out of two nursing units reviewed (Units 2 and 3) and for three out
of eight residents sampled (Residents 1, 5, and 13). Findings include: A review of the facility policy titled
Administering Medications, last reviewed July 28, 2025, revealed it is the facility's policy that medications
are administered in a safe and timely manner and only as prescribed.A review of the facility policy titled
Self-Administration of Medications, last reviewed July 28, 2025, revealed it is the facility's policy that
medications permitted for self-administration are stored in a safe and secure manner and are not
accessible to other residents. The policy further states that if safe storage is not possible in the resident's
room, medications are to be stored on a central medication cart or in the medication room. A clinical record
review revealed Resident 13 was admitted to the facility on [DATE]. Review of a quarterly Minimum Data
Set assessment (MDS, a federally mandated standardized assessment process conducted periodically to
plan resident care) dated November 23, 2025, revealed that Resident 13 is cognitively intact with a BIMS
score of 15 (Brief Interview for Mental Status, a tool within the Cognitive Section of the MDS that is used to
assess the resident's attention, orientation, and ability to register and recall new information; a score of 13
to 15 indicates cognition is intact). A clinical record review revealed a Medication Self-Administration
Screen dated April 16, 2025, which indicated Resident 13 was appropriate for self-administration of
medications. An observation conducted on February 5, 2026, at 9:15 AM revealed an orange oblong pill
partially obscured by papers on the bedside table in Resident 13's room. During an interview conducted on
February 5, 2026, at 9:15 AM, Resident 13 stated the pill must have fallen out of her medication cup. During
an interview conducted on February 5, 2026, at 9:20 AM, Employee 1, Licensed Practical Nurse (LPN),
collected and secured the medication and identified it as methocarbamol 750 mg (a muscle relaxant
medication used to relieve muscle spasms). Employee 1 confirmed Resident 13 had a current physician's
order for methocarbamol 750 mg. An additional observation on February 5, 2026, at 9:24 AM in Resident
room [ROOM NUMBER] revealed two pills and a clear medication cup on the floor near the window-side
bed. One pill was oval shaped and salmon-colored with an 894 imprint. The second pill was yellow and
oblong with a dividing line and an imprint of 1 and 8. During an interview on February 5, 2026, at 9:26 AM,
Employee 2, LPN, confirmed the medications should not have been on the floor and secured the pills.
During an interview on February 5, 2026, at 11:15 AM, the Nursing Home Administrator (NHA) identified
the salmon-colored pill as Eliquis 5 mg (an anticoagulant medication used to prevent blood clots) and the
yellow pill as sertraline 100 mg (a selective serotonin reuptake inhibitor, a class of medication commonly
used to treat depression and anxiety). The aforementioned information was reviewed with the NHA. The
facility failed to ensure the resident
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
395929
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395929
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/05/2026
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Ridgeview Healthcare & Rehab Center
200 Pennsylvania Avenue
Shenandoah, PA 17976
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0689
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
environment was safe from accident hazards, specifically residents having access or ingestion to
unsecured medications A clinical record review revealed Resident 1 was admitted to the facility on [DATE],
with diagnoses to include muscle weakness and osteoporosis (disease where bones become weak,
porous, and brittle, significantly increasing fracture risk). A review of an admission MDS dated [DATE],
revealed that Resident 1 was cognitively intact with a BIMS score of 15. The clinical record review revealed
no documentation indicating Resident 1 had been assessed or approved to self-administer medications.An
observation conducted on February 5, 2026, at 9:30 AM revealed a tube of hydrocortisone 1 percent cream
(a medicated topical corticosteroid used to reduce skin inflammation and irritation) at Resident 1's bedside.
The tube lacked instructions for use, dosage information, and labeling. A review of the clinical record
revealed no physician order for hydrocortisone cream. During an interview on February 5, 2026, at 9:34
AM, Employee 3, Registered Nurse Supervisor, confirmed Resident 1 should not have had the
hydrocortisone cream at her bedside. A clinical record review revealed Resident 5 was admitted to the
facility on [DATE], with diagnosis to include diabetes (a chronic condition characterized by high blood sugar
levels) and muscle weakness. Review of an admission MDS dated [DATE], revealed Resident 5 was
cognitively intact with a BIMS score of 15. An observation conducted on February 5, 2026, at 10:00 AM
revealed a tube of zinc oxide 20 percent ointment (a topical skin protectant used to prevent and treat minor
skin irritation) at Resident 5's bedside. The tube was labeled with the resident's name and room number
written in marker. During an interview at the time of observation, Resident 5 stated staff routinely left the
ointment at her bedside for application. The resident further stated she did not apply the medication herself
but could if she chose to, and that staff routinely left medications at her bedside, the resident stated the
cream is always left at her bedside. During an interview on February 5, 2026, at 11:00 AM, the Nursing
Home Administrator was informed of and reviewed the above findings related to nursing staff leaving
medicated creams and ointments at residents' bedsides, accessible for use, despite residents not having
documentation of assessment or approval to self-administer medications. 28 Pa. Code 201.18 (b)(1)
Management. 28 Pa. Code 211.10 (d) Resident care policies. 28 Pa. Code 211.12 (c)(d)(1)(5) Nursing
services
Event ID:
Facility ID:
395929
If continuation sheet
Page 2 of 2